Commentary on 'Localized pigmentation disorder after subcutaneous pegylated interferon beta 1a injection' by Coghe et al

Subjects

Subjects :

medicine.medical_specialty
03 medical and health sciences
Multiple Sclerosis, Relapsing-Remitting
0302 clinical medicine
Pegylated interferon
Internal medicine
medicine
Humans
030212 general & internal medicine
Beta (finance)
Pigmentation disorder
Interferon beta
business.industry
Multiple sclerosis
Interferon beta-1a
Interferon-beta
medicine.disease
Endocrinology
Neurology
Relapsing remitting
Immunology
Neurology (clinical)
business
Pigmentation Disorders
030217 neurology & neurosurgery
medicine.drug

Details

ISSN :

14770970 and 13524585

Volume :

24

Database :

OpenAIRE

Journal :

Multiple Sclerosis Journal

Accession number :

edsair.doi.dedup.....e9b45508c5406af0f001c9678f835ab5

Full Text :

https://doi.org/10.1177/1352458517719153